Daiwa Securities Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.3M | Buy |
39,673
+345
| +0.9% | +$128K | 0.03% | 301 |
|
|
2026
Q1 | $11.5M | Sell |
39,328
-1,787
| -4% | -$587K | 0.03% | 301 |
|
|
2025
Q4 | $14.4M | Buy |
41,115
+767
| +2% | +$259K | 0.05% | 233 |
|
|
2025
Q3 | $13M | Sell |
40,348
-941
| -2% | -$293K | 0.04% | 241 |
|
|
2025
Q2 | $16.1M | Buy |
41,289
+6,396
| +18% | +$2.57M | 0.06% | 188 |
|
|
2025
Q1 | $15.2M | Buy |
34,893
+2,602
| +8% | +$1.04M | 0.06% | 187 |
|
|
2024
Q4 | $11.9M | Buy |
32,291
+3,190
| +11% | +$1.33M | 0.05% | 202 |
|
|
2024
Q3 | $15.1M | Buy |
29,101
+1,391
| +5% | +$743K | 0.07% | 168 |
|
|
2024
Q2 | $15M | Buy |
27,710
+2,212
| +9% | +$1.17M | 0.08% | 146 |
|
|
2024
Q1 | $13.2M | Buy |
25,498
+2,953
| +13% | +$1.47M | 0.07% | 152 |
|
|
2023
Q4 | $10.6M | Buy |
22,545
+1,346
| +6% | +$622K | 0.07% | 166 |
|
|
2023
Q3 | $9.23M | Sell |
21,199
-832
| -4% | -$377K | 0.07% | 164 |
|
|
2023
Q2 | $9.79M | Sell |
22,031
-7,817
| -26% | -$3.61M | 0.06% | 164 |
|
|
2023
Q1 | $13.7M | Buy |
29,848
+5,611
| +23% | +$2.67M | 0.1% | 124 |
|
|
2022
Q4 | $12.4M | Buy |
24,237
+6,569
| +37% | +$3.34M | 0.1% | 128 |
|
|
2022
Q3 | $8.03M | Buy |
17,668
+537
| +3% | +$257K | 0.07% | 174 |
|
|
2022
Q2 | $8.27M | Buy |
17,131
+1,134
| +7% | +$561K | 0.06% | 169 |
|
|
2022
Q1 | $7.86M | Buy |
15,997
+518
| +3% | +$237K | 0.05% | 205 |
|
|
2021
Q4 | $7.17M | Buy |
15,479
+666
| +4% | +$280K | 0.04% | 227 |
|
|
2021
Q3 | $5.52M | Buy |
14,813
+304
| +2% | +$116K | 0.04% | 241 |
|
|
2021
Q2 | $5.54M | Buy |
14,509
+1,037
| +8% | +$396K | 0.04% | 221 |
|
|
2021
Q1 | $4.84M | Sell |
13,472
-1,126
| -8% | -$362K | 0.04% | 215 |
|
|
2020
Q4 | $4.69M | Buy |
14,598
+2,226
| +18% | +$683K | 0.04% | 220 |
|
|
2020
Q3 | $3.32M | Sell |
12,372
-1,440
| -10% | -$387K | 0.03% | 240 |
|
|
2020
Q2 | $2.74M | Hold |
13,812
| – | – | 0.06% | 177 |
|
|
2020
Q1 | $3.14M | Sell |
13,812
-1,068
| -7% | -$291K | 0.03% | 236 |
|
|
2019
Q4 | $4.49M | Buy |
14,880
+967
| +7% | +$266K | 0.04% | 211 |
|
|
2019
Q3 | $3.34M | Buy |
13,913
+498
| +4% | +$136K | 0.03% | 247 |
|
|
2019
Q2 | $3.79M | Buy |
13,415
+455
| +4% | +$124K | 0.03% | 226 |
|
|
2019
Q1 | $3.72M | Sell |
12,960
-834
| -6% | -$241K | 0.03% | 220 |
|
|
2018
Q4 | $3.62M | Sell |
13,794
-47
| -0.3% | -$12.9K | 0.03% | 226 |
|
|
2018
Q3 | $3.79M | Buy |
13,841
+1,277
| +10% | +$332K | 0.03% | 267 |
|
|
2018
Q2 | $2.99M | Sell |
12,564
-692
| -5% | -$160K | 0.02% | 313 |
|
|
2018
Q1 | $2.91M | Sell |
13,256
-397
| -3% | -$93.3K | 0.02% | 309 |
|
|
2017
Q4 | $3.07M | Sell |
13,653
-8,469
| -38% | -$1.8M | 0.02% | 308 |
|
|
2017
Q3 | $4.2M | Sell |
22,122
-1,028
| -4% | -$196K | 0.03% | 237 |
|
|
2017
Q2 | $4.36M | Buy |
23,150
+2,765
| +14% | +$497K | 0.03% | 220 |
|
|
2017
Q1 | $3.37M | Sell |
20,385
-2,808
| -12% | -$447K | 0.02% | 256 |
|
|
2016
Q4 | $3.33M | Sell |
23,193
-3,307
| -12% | -$443K | 0.02% | 211 |
|
|
2016
Q3 | $3.32M | Sell |
26,500
-3,450
| -12% | -$445K | 0.02% | 218 |
|
|
2016
Q2 | $3.93M | Sell |
29,950
-6,050
| -17% | -$828K | 0.02% | 197 |
|
|
2016
Q1 | $5M | Sell |
36,000
-15,150
| -30% | -$2.02M | 0.03% | 167 |
|
|
2015
Q4 | $7.13M | Sell |
51,150
-20,900
| -29% | -$2.88M | 0.05% | 128 |
|
|
2015
Q3 | $10.1M | Sell |
72,050
-2,900
| -4% | -$436K | 0.07% | 106 |
|
|
2015
Q2 | $12.3M | Buy |
74,950
+57,600
| +332% | +$9.2M | 0.09% | 103 |
|
|
2015
Q1 | $2.68M | Buy |
17,350
+10,150
| +141% | +$1.45M | 0.02% | 237 |
|
|
2014
Q4 | $905K | Sell |
7,200
-550
| -7% | -$68K | 0.01% | 331 |
|
|
2014
Q3 | $927K | Sell |
7,750
-50
| -0.6% | -$5.74K | 0.01% | 302 |
|
|
2014
Q2 | $839K | Sell |
7,800
-600
| -7% | -$61.8K | 0.01% | 320 |
|
|
2014
Q1 | $836K | Sell |
8,400
-700
| -8% | -$63.3K | 0.01% | 313 |
|
|
2013
Q4 | $841K | Buy |
9,100
+500
| +6% | +$44.4K | 0.01% | 296 |
|
|
2013
Q3 | $719K | Sell |
8,600
-3,600
| -30% | -$309K | 0.01% | 319 |
|
|
2013
Q2 | $998K | Buy |
+12,200
| New | +$913K | 0.01% | 288 |
|
Other funds holding ELV
Daiwa Securities Group's ELV Position: Q2 2026 in Review
Daiwa Securities Group increased its Elevance Health (ELV) stake by 0.88% in Q2 2026, buying an estimated $128K and bringing the position to 39,673 shares worth $15.3M. The position accounts for 0.03% of the portfolio, ranked #301.
Daiwa Securities Group first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.1M in Q2 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Daiwa Securities Group held 39,673 shares of Elevance Health worth $15.3M as of Q2 2026.
- Daiwa Securities Group bought 345 Elevance Health shares in Q2 2026, an estimated $128K.
- Elevance Health made up 0.03% of Daiwa Securities Group's portfolio in Q2 2026, its #301 holding.
- Daiwa Securities Group first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Daiwa Securities Group's Elevance Health position peaked at $16.1M in Q2 2025.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.